No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Otrexup is a market of immune disorder drugs used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and ankylosing spondylitis. These drugs are designed to reduce inflammation and pain, and to slow or stop the progression of the disease. They are typically administered through injections or infusions, and may be taken orally as well. The drugs are typically prescribed by a doctor, and may be used in combination with other treatments.
The Otrexup market includes a variety of companies, such as AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and UCB. These companies produce a range of drugs, including biologics, small molecules, and biosimilars. They also provide support services, such as patient education and access programs. Show Less Read more
